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In this paper we describe the modification and assessment of a standard multidistance
frequency-domain near infrared spectroscopy NIRS instrument to perform multifrequency
frequency-domain NIRS measurements. The first aim of these modifications was to develop an
instrument that enables measurement of small volumes of tissue such as the cervix, which is too
small to be measured using a multidistance approach. The second aim was to enhance the spectral
resolution to be able to determine the absolute concentrations of oxy-, deoxy- and total hemoglobin,
water, and lipids. The third aim was to determine the accuracy and error of measurement of this
novel instrument in both in vitro and in vivo environments. The modifications include two frequency
synthesizers with variable, freely adjustable frequency, broadband high-frequency amplifiers, the
development of a novel avalanche photodiode APD detector and demodulation circuit, additional
laser diodes with additional wavelengths, and a respective graphic user interface to analyze the
measurements. To test the instrument and algorithm, phantoms with optical properties similar to
those of biological tissue were measured and analyzed. The results show that the absorption
coefficient can be determined with an error of 10%. The error of the scattering coefficient was
31%. Since the accuracy of the chromophore concentrations depends on the absorption coefficient
and not on the scattering coefficient, the 10% error is the clinically relevant parameter. In
addition, the new APD had similar accuracy as the standard photomultiplier tubes. To determine the
accuracy of chromophore concentration measurements we employed liquid Intralipid® phantoms
that contained 99% water, 1% lipid, and an increasing concentration of hemoglobin in steps of
0.010 mM. Water concentration was measured with an accuracy of 6.5% and hemoglobin
concentration with an error of 0.0024 mM independent of the concentration. The measured lipid
concentration was negative, which shows that the current setup is not suitable for measuring lipids.
Measurements on the forearm confirmed reasonable values for water and hemoglobin
concentrations, but again not for lipids. As an example of a future application, chromophore
concentrations in the cervix were measured and comparable values to the forearm were found. In
conclusion the modified instrument enables measurement of water concentration in addition to oxy-
and deoxyhemoglobin concentrations with a single source-detector distance in small tissue samples.
Future work will focus on resolving the lipid component. © 2009 American Institute of Physics.
DOI: 10.1063/1.3082024
I. INTRODUCTION
Biological tissue exhibits relatively low absorption in the
near infrared range, 650–1000 nm, and light in this wave-
length range penetrates tissue relatively deeply. Near infrared
spectroscopy NIRS has been successfully applied in medi-
cine for a variety of noninvasive diagnostic purposes, e.g., to
quantitatively investigate the oxygenation, blood flow, vol-
ume, or function of tissues such as the breast, muscle, or
brain.1–4 Various techniques have been developed for this
purpose. Continuous wave spectroscopy employs light
sources with constant intensity to determine changes in at-
tenuation. However, this enables only measurement of
changes in chromophore concentrations and not absolute val-
ues. To determine absolute values the absorption a in
1/cm and reduced scattering s in 1/cm coefficients of
tissue must be quantified. Chromophore concentrations can
then be calculated from a values. Measurement of a val-
ues is achieved either by time-domain spectroscopy, which
records the dispersion of extremely short pulses of light by
tissue, or by frequency-domain spectroscopy, which assesses
the phase shift  and amplitude A of intensity modulated
light. Here, we focus on frequency-domain spectroscopy.
There are two basic frequency-domain modes: the multidis-
tance mode, which measures  and A at several different
source-detector distances, but at a single modulation fre-
quency, and the multifrequency mode, which measures 
and A at a single source-detector distance, but at several
different modulation frequencies.5 The multidistance method
has a higher signal to noise ratio but assumes a relatively
large volume of homogeneous tissue of 250 ml. For many
clinical applications this assumption is fulfilled. However,
other clinical situations necessitate small volume measure-
ments. To increase the scope of clinical applications and the
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potential of NIRS it is then desirable to enable measurements
on smaller tissue volumes. The multifrequency method is
ideally suited for smaller volumes of tissue in the range of
30 ml. This extends the range of clinical applications to
smaller organs or tissues such as the cervix. While multidis-
tance instruments are commercially available,5,6 multifre-
quency instruments are not yet available on the market.
Therefore the aims of this work are the following:
• Transform a commercial ISS Inc. Champaign, Illinois,
USA frequency-domain multidistance instrument to a
multifrequency mode instrument, which enables measure-
ments on small tissues at a single source-detector distance,
• To enhance the spectral resolution to enable quantitative
detection of oxy-, deoxy-, and total hemoglobin O2Hb,
HHb, and tHb, as well as water and lipid concentrations,
and
• To test the accuracy and error of measurements, thus char-
acterizing the properties of the novel instrument in vitro
and in vivo.
II. INSTRUMENTATION
The commercially available ISS Inc. Imagent® multi-
distance instrument that was transformed originally featured
four photomultiplier tubes PMTs as detectors and 32 laser
diodes as light sources, 16 at 690 nm and 16 at 830 nm. The
emitted light intensity is modulated at 110 MHz.6 The light
sources are time multiplexed, i.e., only one light source is on
at a time. The light is coupled to fibers 400 m diameter
that guide light to the tissue. After penetrating the tissue
the light is received and guided back to the instrument by
another fiber 3 mm diameter, where it is detected by a PMT
modulated at 110 005 kHz. The demodulated signal at
5 kHz is amplified and digitized in a computer Datel PCI-
416-M2 PCI ADC board. The computer also generates the
timing signals PCI-CTR05 PCI board. A software com-
putes  and A by fast Fourier transform FFT and calculates
the a and s and absolute concentrations of O2Hb, HHb,
tHb, and the regional tissue oxygen saturation StO2. The sen-
sor implements a multidistance geometry, i.e., usually  and
A are measured at four different distances ranging from 1.5
to 5 cm. In theory, it is assumed that the tissue below the
sensor is homogeneous.5 Thus, this technique has been suc-
cessfully applied in many types of tissue with a volume of
250 ml. It would however be advantageous to extend
the range of applications to small volumes of tissue such as
the cervix. Additionally, the commercial instrument detectors
are insensitive to wavelengths above 880 nm and thus chro-
mophores such as water and lipids, whose absorption peaks
are above 900 nm, cannot be detected.
A. Modified ISS Inc. multifrequency frequency-
domain instrument
To extend the range of NIRS to smaller tissue volumes
and to enable measurement of water and lipids, a commer-
cially available Imagent® has been modified in collaboration
with ISS Inc.
To enable the multifrequency mode, the two original
synthesizers with fixed frequencies were replaced by two fre-
quency generators PTS 500, whose frequency can be freely
adjusted from 50 to 500 MHz. A new broadband amplifier
delivers the modulation frequency to the laser diodes and
detectors. The BOXY ISS Inc. software that controls the
instrument was modified to control the two frequency gen-
erators. Compared to network analyzers7 our setup decreases
the sample time from 60 to 10 s and enables continuous
measurements at a time resolution better suited for physi-
ological measurements.
To be able to also measure water and lipid, the instru-
ment was modified to measure at more, and also at higher,
wavelengths. This required modifications of both the light
sources and detectors. In the multifrequency mode, only one
laser diode is needed per wavelength. Thus, one laser board
was equipped with eight different laser diodes at the follow-
ing wavelengths in brackets the chromophore/s for which
the respective wavelength is relevant: 690 nm HHb, 692
nm HHb, 764 nm HHb, 831 nm O2Hb, 872 nm O2Hb,
888 nm O2Hb, lipid, 914 nm lipid, water, and 980 nm
water.
The standard PMT detectors R926, Hamamatsu Photo-
nics, Japan of the ISS Inc. instrument have several disad-
vantages. They are relatively expensive, fragile an excess of
light may destroy the PMT, a situation that can easily occur
in a clinical environment, and need a high supply voltage of
1 kV. Their spectral sensitivity decreases rapidly at 800 nm,
which makes it impossible to detect water and lipid spectra
above 880 nm. In addition the frequency response of the
PMT decreases above 400 MHz. However, they have a high
internal gain and a large detection area. For our low-level
light application, we have chosen an avalanche photodiode
APD as light detector because it offers a broader spectral
range including the wavelengths required for water and lipid
detection. The APD also has a higher sensitivity, improved
quantum efficiency compared to the PMT detector, and a
higher signal to noise ratio than a PIN photodiode. To imple-
ment the APD two circuit boards were designed and pro-
duced, one to generate the high voltage for the APD, and the
APD demodulation board with the APD itself and all the
filters.
The reverse bias voltage of the APD is delivered by the
TR-0.2P high-voltage power supply Matsusada. It has an
output voltage of 0–200 V and temperature compensation.
The voltage is controlled by a potentiometer.
The intensity of the laser diodes can be modulated from
50 to 500 MHz. The APD detector is modulated at a fre-
quency that is always 5 kHz above the laser diodes. Thus, at
the detector the frequency is mixed down to 5 kHz. This is
achieved by heterodyne modulation of the reverse voltage of
the APD. It consists of high-voltage and high-frequency ele-
ments. These are connected by inserting a capacitor as a dc
blocker on the high-frequency element and inductivity as a
high frequency blocker on the high-voltage side on the APD
demodulation board Fig. 1.
For instance, when the incident light is modulated with
50 MHz and the APD with 50 MHz+5 kHz, then the result-
ing signal contains the  and A information in a 5 kHz wave.
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The higher frequencies are suppressed by a lowpass filter,8
which is attached to the anode of the APD. It is followed by
a transimpedance amplifier to convert the current into a volt-
age. A feedback capacitance over the operational amplifier is
applied in order to avoid oscillations of the system. The 5
kHz signal is connected to an active bandpass filter, which is
implemented as a two-pole fourth order multifeedback
filter.9 It works with only one operational amplifier to serve
the intended purpose. The source impedance must be low
with respect to the input resistance with the transimpedance
amplifier as the source. This implementation only allows a Q
value of 2 to 5 and the amplification is −2Q2. To ensure the
stability of the system, the amplification of the operational
amplifier should be at least 20Q2 at the resonance frequency.
An amplifier is connected to the output of the bandpass filter
to enable reasonable values for the analog-digital converter
board of the computer. The  and A are calculated digitally
by FFT.
III. THEORY
In the following we describe how the concentration of
O2Hb, HHb, water, and lipid can be calculated from the 
and A. The underlying theory of multifrequency frequency-
domain spectroscopy has been described in detail
elsewhere.10 Briefly, the propagation of light through
a highly scattering medium absorption coefficient a
 reduced scattering coefficient s is described by the dif-
fusion approximation to the Boltzmann transportation equa-
tion. The diffusion equation describes the propagation of a
photon density wave
− Dr2r,t + ar,t +
1
c
r,t
t
= q0r,t 1
with r as the source-detector distance, t as the time, q0 as the
modulated point source, D as the diffusion coefficient, and
r , t as the space- and time-dependent photon density.
The light velocity in the medium can be calculated using
c= 3108 m /s /n, where n is the refractive index for the
medium.
The diffusion equation can be solved by assuming a
semi-infinite medium, which approximately corresponds to
the case in many clinical applications. The partial-current-
extrapolated-boundary unification is an accurate representa-
tion of the boundary condition. For details about the theory
and application see Ref. 11.
The two measurable quantities of a photon density wave,
the phase lag lag
m
, and the amplitude Aattm can be theoretically
simulated. For a given a, s, and modulation frequency 
of the point source, the solution to the diffusion equation can
be solved and the theoretical phase lag lag
th  ,a ,s and
amplitude attenuation Aatt
th  ,a ,s calculated.
11
A. Calibration and curve fitting
Since the various instrument factors such as source
power, detector gain, losses due to the source, and detector
fiber are unknown and cannot be eliminated, the instrument
needs to be calibrated. This calibration is done by measuring
the phase lag lag
m and amplitude Aattm over all employed
modulation frequencies on a phantom with known optical
properties similar to tissue. A comparison between the ob-
tained values with the theoretical phase lag lag
th  ,a ,s
and amplitude attenuation Aatt
th  ,a ,s leads to the
modulation-frequency-dependent correction factor Aattc 
and term lagc ,
Aatt
c  =
Aattphantom
m 
Aattphantom
th 
, 2
lag
c  =lagphantom
m  −lagphantom
th  .
This correction factor and term are then applied to biological
tissue measurements to eliminate the unknown instrumental
factors
Aatt
mc =
Aatt
m 
Aatt
c 
, atttissue
mc  =lagtissue
m  −lag
c  .
3
Aatt
mc and lagmc are the calibrated measurement values of
the tissue under investigation at a specific modulation fre-
quency. A recursive fitting procedure is used to determine the
a,tissue and s,tissue for which the corresponding Aatt
th and
lag
th show the best agreement to the calibrated measure-
ment values Aatt
mc and lagmc. More explicitly, a least
squares Gaussian–Newton algorithm with varying a,fit and
s,fit is applied to minimize the following expression over all
modulation frequencies n:

n
Aatt
th n,a,fit,s,fit  − Aatt
mcn,a,tissue,s,tissue 
2
+ 	lag
th n,a,fit,s,fit  −lag
mcn,a,tissue,s,tissue 	
2
 .
4
The factor 	 adjusts the magnitude of the phase difference to
that of the amplitude attenuation, meaning that differences in
phase and amplitude have the same impact on the fitting
FIG. 1. Color online APD demodulation board, high voltage and high
frequency parts of APD, lowpass and transimpedance amplifier.
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procedure. It is also possible to fit lag or Aatt by themselves
minimizing the differences for each variable separately;
however, fitting both simultaneously increases the robustness
of the fit.12
B. Determining the physiological properties
Once a and s of the measured tissue have been deter-
mined, the physiological concentrations of interest, mainly
O2Hb, HHb, water, and lipid, can be calculated. For a given
wavelength 
, the relation between a and the concentration
of the mentioned absorbers is
a


= HHb

 cHHb + O2Hb

 cO2Hb + H2O

 cH2O
+ lipid

 clipid, 5
where x

 is the molar extinction coefficient of absorber x at
wavelength 
 and cx is the concentration of absorber x.
Equation 5 can also be written in the matrix form
 a = ln10 · E · c , 6
where E is the extinction matrix and c the concentration
vector13
E = HHb,
1 O2Hb,
1 H2O,
1 lipid,
1] ] ] ]
HHb,
n O2Hb,
n H2O,
n lipid,
n
, c =
cHHb
cO2Hb
cH2O
clipid
 .
7
To calculate the concentrations in Eq. 6, the equation and
hence the extinction matrix have to be inverted. In this case
where the system is overdetermined more wavelengths than
absorbers, the Gaussian normal equation, a least-squares
procedure minimizing the error, is applied,
c =
1
ln10
ET · E−1ET a. 8
To calculate chromophore concentrations, the values of the
extinction coefficients of hemoglobin and water were taken
from the literature.14–17 For lipid we used the spectra of pork
lipid.16
IV. GRAPHICAL USER INTERFACE
To analyze the data and calculate the optical properties a
graphical user interface was programmed. It enables graphi-
cal inspection of the results of the calibration, measurement,
and fitted lines. Furthermore, from the raw optical data the
optical properties of the sample are calculated for each wave-
length and the chromophore concentrations determined. Mo-
tion artifacts sometimes occur in clinical situations and may
lead to unacceptable data. The graphic user interface enables
immediate analysis and detection of such problems. Thus,
often it will be possible to carry out another measurement
without motion artifacts.
V. MEASUREMENTS
To test the reproducibility, reliability, and accuracy of
the modified instrument and algorithms, several experiments
were performed:
• Measurements on silicone phantoms with known optical
properties,
• Measurements of an Intralipid® solution with known chro-
mophore concentrations, and
• In vivo measurement on a male human forearm for a com-
parison with values from the literature. Additionally, mea-
surements on the human cervix were performed to show
the feasibility of the method for small tissue investigations.
For all measurements a single-distance reflection sensor
with a source-detector separation of 1.5 cm was used mean
penetration depth of 5 mm. The following eight laser di-
odes of the instrument were used: 980, 914, 888, 872, 805,
764, 692, and 690 nm. The measurements were recorded
with modulation frequencies ranging from 130 to 490 MHz
in 10 MHz steps. The modulation frequency range for the
analysis of all measurements was constrained to 130–400
MHz due to resonance effects below 130 MHz, significantly
increasing noise for modulation frequencies above 400 MHz
and to optimize the signal to noise ratio.
VI. SILICONE PHANTOM MEASUREMENTS
An array of four silicone phantoms with known optical
coefficients Table I specified by the manufacturer ISS Inc.
was selected to test the instrumental accuracy of the modified
instrument. For comparison, the experiments were once per-
formed with the APD and once with the PMT.
Each phantom was measured three times in an alternat-
ing order. First, the measurements were recorded by the
PMT, then by the APD. For the analysis, a phantom i.e.,
calibration phantom was used to calibrate for the instrumen-
tal factors while optical properties of another phantom
i.e., measurement phantom were measured. As the respec-
tive calibration phantom we chose the one with the a clos-
est to the one of the measurement phantom. The analysis was
performed for each combination of a specific calibration-
measurement phantom pair. For instance, for phantom 1 as
measurement phantom and phantom 4 as calibration phan-
tom, each measurement of phantom 1 was calibrated with
each measurement of the calibration phantom 4. For three
measurements on each phantom this yields nine combina-
tions, i.e., nine estimates of a and s for the measurement
phantom 1. a and s were averaged for each wavelength
and the error 100 measured value-actual value/actual
value and standard deviation SD of a and s calculated.
Since the spectral range of the PMT is limited to 880
nm, the error for the wavelengths of 888, 914, and 980 nm
were higher than 100% and increasing with the wavelength.
For the other wavelengths, the error for a was constant and
10%. The APD showed no wavelength-dependent change
in the accuracy of the measured optical properties, i.e., the
error was very similar for all wavelengths for a and s. For
a the error was 10% for all wavelengths. Since the errors
were very similar across wavelengths, in Table I the errors
024301-4 Spichtig et al. Rev. Sci. Instrum. 80, 024301 2009
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for a and s were averaged across all wavelengths for the
APD and across all wavelengths 880 nm for the PMT.
Table I shows that the error increases with the difference
in the absorption between calibration and measurement
phantom. For example the largest error was found for mea-
surement phantom 3 and calibration phantom 1 with the larg-
est a=0.021 cm−1. The same is true for the s: the errors
for s increase with the size of the s between calibration
and measurement phantom e.g., for phantom 1 versus phan-
tom 4 s=6 cm−1 and for phantom 2 versus phantom
4 s=0.1 cm−1. Since the accuracy of the chromophore
concentrations depends on the a and not on the s, the error
in a10% is the clinically relevant parameter.
This has implications for measurements on tissue. It is
advisable to use a calibration phantom with similar optical
properties as the tissue under investigation. The observed
effect may be due to some instrumental nonlinearities which
lead to calibration errors that depend on the difference be-
tween calibration and measurement phantoms.
Summarizing the results, for all wavelengths the APD
provides approximately the same accuracy as the PMT.
However, the APD enables detection of wavelengths above
880 nm, which includes absorption peaks of lipids and water.
The small SD of the error demonstrates that the reproducibil-
ity of the measurements is high, demonstrating proper func-
tioning of the instrument.
VII. INTRALIPID® MEASUREMENTS
The main purpose of the measurements in an Intralipid®
phantom was to test whether chromophore concentrations
can be determined accurately. Thus, not only the instrumen-
tal accuracy but also the algorithms used to calculate optical
properties and chromophore concentrations were tested. The
Intralipid® phantom is a liquid emulsion, which has similar
a and s to human tissue, and the concentrations of water,
lipids, and tHb are known.
The APD detector, the same frequency range, and wave-
lengths were used as described above. Again, the calibration
was performed with two silicone phantoms from ISS Inc.
phantoms 1 and 2 in Table I. The Intralipid® phantom con-
sisted of 99% water with 1% Intralipid® and an increasing
amount of hemoglobin. Intralipid® without hemoglobin at
this dilution is an emulsion of lipids, which has similar s as
tissue, i.e., s9.71 cm−1 at 633 nm.
18 We added constant
amounts of red cell concentrate the hemoglobin content was
determined beforehand by blood gas analysis ABL 835, Ra-
diometer Copenhagen in ten steps, increasing the tHb con-
centration by 0.010 mM with each step. This tHb is used as
the reference value and is called the “actual concentration of
tHb.” The Intralipid® solution was maintained at a constant
temperature of 37 °C using a temperature controlled bath
mixed with a magnetic mixer to ensure homogeneity of the
solution and avoid sedation.
In total nine calibrations per silicone phantom were re-
corded: three before, three between, and three after the
Intralipid® phantom measurements. Each specific tHb con-
centration in the Intralipid® phantom was also measured
three times and for the analysis every single measurement
was calibrated with two both phantoms times nine calibra-
tion measurements. The resulting 54 optical coefficients for
each tHb concentration of the Intralipid® phantom were then
averaged to obtain mean and SD, which are displayed in Fig.
2.
With our instrument we determined the optical coeffi-
cients of a=0.161 cm−1 and s=11.56 cm−1 at 690 nm.
These coefficients were measured with 0.010 mM of tHb.
Since no data were recorded without hemoglobin in the In-
TABLE I. Results of the measurements on the silicone phantoms for the APD and the PMT detectors. The mean
error and SD of the measured optical properties compared to the optical properties at 690 nm specified by the
manufacturer ISS Inc. are listed.
Detector
Measurement
phantom no.
Optical propertiesa
Calibration
phantom no.
Error of aSD
%
Error of sSD
%
a
cm−1
s
cm−1
PMT 1 0.125 4.9 4 4.772.15 26.474.37
2 0.104 11.0 4 2.541.82 0.630.33
3 0.146 4.1 1 10.001.18 9.782.81
4 0.115 10.9 2 2.551.87 0.630.39
APD 1 0.125 4.9 4 3.702.07 30.603.29
2 0.104 11.0 4 2.030.98 1.630.61
3 0.146 4.1 1 9.902.77 11.773.54
4 0.115 10.9 2 2.091.00 1.650.57
aMeasured at 690 nm by the manufacturer ISS Inc.
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FIG. 2. Correlation of the actual tHb dotted line and the one measured by
the modified NIRS instrument solid line.
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tralipid® phantom, we subtracted the absorption of the tHb
and received a=0.049 cm−1 for the pure Intralipid® phan-
tom. Compared to the published optical coefficients18 of a
0.0169 cm−1 and s9.71 cm−1 at 633 nm the measured
ones show good agreement, taking into account that the op-
tical coefficients vary from batch to batch.
The measured tHb correlated well with the actual values
Fig. 2, except for the 0.050 and 0.100 mM actual tHb. The
reason for this error at 0.050 and 0.100 mM tHb is that the
measured s for the 980 nm wavelength were overestimated
by a factor 3–4. This led to large errors in the water concen-
tration but has also affected the tHb. Since our instrument is
designed for tissue, which has a lower concentration of water
than the Intralipid® phantom with 99% water concentration,
the signal at the 980 nm wavelength was relatively small
because the absorption peak of water is at this wavelength.
Therefore the signal to noise ratio at 980 nm was comparably
low, which leads to high sensitivity to motion artifacts and
probably led to the large s values. In a real measurement in
tissue, an error of this size would lead to the elimination and
repetition of the measurement.
To analyze the agreement between the actual and
measured tHb concentrations, we calculated the mean
differencestandard deviation between the two concentra-
tions measured-actual according to the literature:19
tHb=0.00880.02 mM for all measurements Fig. 3.
These values are strongly affected by the two outliers 0.050
and 0.100 mM. When these were removed, a mean of the
differences of −0.00120.0024 mM was obtained, which
was 5–10 times smaller than the lowest measured concentra-
tion. This indicates a high degree of accuracy of the mea-
sured concentrations, provided outliers are detected by their
erroneous s and removed.
The concentration of water and lipid in the Intralipid®
emulsion was nearly constant throughout the experimental
series because the total volume of the solution was 400 ml
and the addition of 0.010 mM of hemoglobin corresponded
to an addition of only 1.6 ml of red cell concentrate. There-
fore, for water as well as lipid all measurements were aver-
aged, resulting in a water concentration of 58.68.3 M.
Since the Intralipid® phantom consisted of 99% water, a
concentration of 55 M was expected. Thus, the water con-
centration was determined with a mean error of 6.5%.
The lipid concentration of −408139 mM was nega-
tive instead of close to 0 mM, which is erroneous. Thus, this
experiment revealed that the lipid cannot be accurately mea-
sured with the current setup. There are two possible reasons
for these erroneous results: 1 the implemented spectrum of
porcine lipid may not match the actual spectrum of In-
tralipid® and 2 the silicone of the phantom has an absorp-
tion peak at 910 nm close to the wavelength of 914 nm.
Although we have tried to correct for this absorption peak,
the interpolation may not match the actual spectrum and we
did not have the means to measure the actual spectrum of the
calibration phantoms. We simulated small variations in the
calibration of this peak and they considerably affected the
measured lipid concentrations. Therefore we will measure
the spectrum of the calibration phantom in the future in an
attempt to overcome this problem. Once the spectra are ob-
tained, the measured data can still be reanalyzed, but for the
moment we conclude that the measurement of the lipid con-
centration is inaccurate.
In summary, the experiment demonstrates the impor-
tance of testing the accuracy of the instrument and algorithm.
It also shows the feasibility of reliably and accurately mea-
suring the tHb and water concentration but not lipid concen-
tration by our instrument.
VIII. IN VIVO MEASUREMENTS
To test the modified instrument and analysis with an in
vivo application, measurements on a male human forearm
were performed and the results were compared to values pre-
viously presented in the literature. The APD detector, the
same frequency range, and wavelengths were used as de-
scribed above. For the calibration, two silicone phantoms
from ISS Inc. phantoms 1 and 2 of Table I were used.
The measurements were performed in the following or-
der: forearm, phantom 1, and phantom 2. The procedure was
repeated three times. Each forearm measurement was cali-
brated with each phantom measurement and the mean and
SD for each wavelength and chromophore concentration
were calculated Table II.
The measured concentrations of HHb, O2Hb, tHb, and
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FIG. 3. Graphical representation of the difference in tHb concentration
measured-actual, the mean of the difference prominent dotted line, SD
of the difference dotted line with and without outliers.
TABLE II. Measured optical coefficients and chromophore concentrations
for the forearm of a male subject.
Human forearm
Optical properties
Chromophore concentrationnm
a
cm−1
s
cm−1
690 0.1290.003 8.100.91 HHb 0.01730.0006 mM
692 0.1240.007 7.490.75 O2Hb 0.04210.005 mM
764 0.1410.006 7.030.77 tHb 0.05940.005 mM
831 0.1300.007 6.880.74 StO2 70.72.7%
872 0.1640.014 6.580.78 H2O 22.981.34 M
888 0.1920.017 6.460.71 Lipid −116.6137.3 mM
914 0.1720.018 5.90.63
980 0.3300.007 5.870.55
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StO2 values are similar to published data.20 Also the SDs of
the hemoglobin and water concentrations are small, corre-
sponding to an error of measurement of 3.5% for HHb,
11.9% for O2Hb, 8.4% for tHb, and 3.8% for StO2. Since it is
expected that the concentration of the chromophores is not
completely stable in living tissue, the true error may even be
smaller.
A water concentration of 23.01.3 M was obtained,
which corresponds to a tissue water content of
41.372.41%. From the literature, water concentration of
784% in the male human forearm muscle and 209% in
the adipose tissue have been published.14 Since adipose tis-
sue is present between muscle and the skin and due to the
small mean penetration depth 0.5 cm of the sensor, it is
likely that mixture of muscle and adipose tissue was mea-
sured. A tissue water content of 41.37%, i.e., a value between
adipose tissue and muscle, seems reasonable. It is quite clear,
however, that this is only a relatively imprecise estimate. The
SD of repeated measurements and thus the error of measure-
ment at 5.8% were small for water.
As in the Intralipid® experiment, the estimation of the
actual lipid concentration yielded a negative value and thus
was inaccurate. Possible reasons have been discussed above.
Thus, we conclude that for the HHb, O2Hb, tHb, StO2,
and water, the in vivo measurement yields reasonable values
and an acceptable error of measurement for clinical research
applications.
To show that the method is suitable for investigations of
small tissue volumes, the same setup was used to perform
measurements of the cervix on two test subjects. The results
are shown in Table III. Since no other data on cervix chro-
mophore concentrations have previously been published, we
can only demonstrate the feasibility but not the accuracy of
the method.
The measured HHb, O2Hb, and tHb are higher than the
values on the male human forearm but still within a reason-
able range. Water concentrations also compare favorably to
those measured in the male human forearm. As before, esti-
mation of the measured lipid concentration yielded a nega-
tive value and thus was inaccurate. Possible reasons for this
have been discussed above.
In conclusion, in the cervix reasonable values for O2Hb,
HHb, and water were obtained.
IX. CONCLUSIONS
In this work we present the modification and assessment
of a commercially available frequency-domain NIRS instru-
ment adapted from a multidistance instrument to a multifre-
quency frequency-domain NIRS instrument to enable mea-
surements in small volume of tissue. The algorithms used to
determine optical coefficients and concentrations of HHb,
O2Hb, tHb, lipid, and water were implemented in a graphical
user interface. The instrument was tested in solid and liquid
phantoms as well as in in vivo settings. The results show that
thorough testing in vitro and in vivo is essential to assess the
strengths and weaknesses of an instrument and they demon-
strate the capability of the modified instrument to accurately
quantify both a and s and all chromophore concentrations
except for lipids in highly scattering media, thus providing
the necessary background information for further clinical in-
vestigations. There are numerous clinical applications for
this noninvasive method, which include, but are not limited
to, organs with small volumes such as the hand, foot, tongue,
and cervix, the latter to monitor cervical ripening during
pregnancy.21
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TABLE III. Measured chromophore concentrations for the cervix of two test
subjects.
Cervix: chromophore concentration
Test subject 1 Test subject 2
HHb 0.0220 mM HHb 0.0145 mM
O2Hb 0.0734 mM O2Hb 0.060 mM
tHb 0.0954 mM tHb 0.0745 mM
StO2 76.9% StO2 80.5%
H2O 24.95 M H2O 19.56 M
Lipid 730.61 mM Lipid 766.65 mM
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